For a long time, antibiotics were the typical treatment for Lyme disease. However, there is news of a promising new Lyme disease treatment that patients can potentially benefit from. Understanding these new treatments for Lyme disease can be helpful so that you can make an informed decision about your treatment, ensuring that you have the best outcomes that you can for your situation. Reading on, you can learn more about the different treatment options available to treat Lyme disease.

Traditional Treatments Used for Lyme Disease

Traditionally, Lyme disease would be treated using tetracycline antibiotics. Unfortunately, between 10% and 20% of people who suffer from Lyme disease end up with symptoms later on including fatigue, joint pain, muscle pain, and cognitive impairment. These are symptoms that you may end up suffering from could last for months or even several years after you have completed treatment. There are even potentially types of Lyme disease that may be “drug-tolerant persisters”, which are cells of bacteria that survived the original course of antibiotic treatments.

There is also the possibility of an immune disorder that is caused when you are first infected with the bacteria, which can create a perpetual inflammation condition.

This means that the traditional treatments used for Lyme disease may not be as effective as you would think.

New Treatments for Lyme Disease

There is a new treatment that is being looked at that has shown some promise in being highly effective in treating Lyme disease. The goal was to find out if there were drug options that could kill the bacteria better than the traditional medications used for Lyme disease. This is where they noticed azlocillin. During the research on finding potentially better treatments, researchers noticed that azlocillin could kill drug-resistant cells of this bacteria at higher doses. It performed much better in these cases than the traditional antibiotics used for treating Lyme disease.

While further studying this medication, azlocillin completely cleared the Lyme disease infection while it was in the early stages. They continued to monitor the mice in these studies to see just how effective azlocillin was for treating Lyme disease. These studies have shown that there is a lot of promise in just how effective this new treatment option could be for patients.

There haven’t been any human trials on this topic, but the teams are working hard to create a compound of this for treating Lyme disease.

Conclusion

Lyme disease is a condition that is notoriously hard to catch early and is often misdiagnosed before it is properly diagnosed. The difficulties revolving around how hard it is to diagnose this condition is one reason why it’s so hard to effectively treat Lyme disease. Traditional treatments only work if the disease is caught early, but even then, there is no guarantee that the medication will be effective in treating this condition. However, there is some promising evidence coming out of the studies about azlocillin, which can potentially be an excellent treatment even for the more difficult cases of Lyme disease.